Skip Navigation

ATRYS HEALTH

Profile

Atrys Health (BME:ATRY), founded in 2015, is a global medical services provider with more than 2,200 professionals and presence in 8 countries. A pioneer in the fields of telemedicine and state-of-the-art radiotherapy, it has a solid track record of organic and inorganic growth with the integration of 14 companies since 2018.

Atrys focuses its activity around three business units: prevention, diagnosis and oncology. Through these three areas, provides a 360º service, covering everything from prevention to cancer treatment, including precision diagnosis and the use of telemedicine. Thus, the company performs diagnostic tests, analyses using telemedicine tests on radiology, cardiology, ophthalmology and dermatology and provides medical oncology services carrying out chemotherapy, immunotherapy and advanced radiotherapy treatments.

Research

144 KBMorningstar - Quantitative Report (5 February 2023 08:15)

Video Gallery

Interview with Isabel Lozano
CEO of Atrys Health

08/02/2022

BME welcomes Atrys Health as it moves from BME Growth to the stock exchange

07/02/2022

Atrys Health
Resumen Discovery Meeting
Foro Medcap 2019

01/07/2019

Atrys Health
Resumen Discovery Meeting
Foro Medcap 2017

20/07/2017

Santiago de Torres, Presidente
Atrys Health

22/07/2016